Literature DB >> 29472124

Design, synthesis and biological assessment of N-adamantyl, substituted adamantyl and noradamantyl phthalimidines for nitrite, TNF-α and angiogenesis inhibitory activities.

Weiming Luo1, David Tweedie1, Shaunna L Beedie2, Neil Vargesson3, William D Figg4, Nigel H Greig5, Michael T Scerba1.   

Abstract

A library of 15 novel and heretofore uncharacterized adamantyl and noradamantyl phthalimidines was synthesized and evaluated for neuroprotective and anti-angiogenic properties. Phthalimidine treatment in LPS-challenged cells effected reductions in levels of secreted TNF-α and nitrite relative to basal amounts. The primary SAR suggests nitration of adamantyl phthalimidines has marginal effect on TNF-α activity but promotes anti-nitrite activity; thioamide congeners retain anti-nitrite activity but are less effective reducing TNF-α. Site-specific nitration and thioamidation provided phthalimidine 24, effecting an 88.5% drop in nitrite concurrent with only a 4% drop in TNF-α. Notable anti-angiogenesis activity was observed for 20, 21 and 22. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29472124      PMCID: PMC5891396          DOI: 10.1016/j.bmc.2018.01.032

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  59 in total

1.  In vivo imaging of embryonic vascular development using transgenic zebrafish.

Authors:  Nathan D Lawson; Brant M Weinstein
Journal:  Dev Biol       Date:  2002-08-15       Impact factor: 3.582

Review 2.  Nitric oxide signaling and nitrosative stress in neurons: role for S-nitrosylation.

Authors:  Neelam Shahani; Akira Sawa
Journal:  Antioxid Redox Signal       Date:  2011-02-17       Impact factor: 8.401

3.  TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition.

Authors:  Jian Y Zou; Fulton T Crews
Journal:  Brain Res       Date:  2005-02-09       Impact factor: 3.252

Review 4.  Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type.

Authors:  A Law; S Gauthier; R Quirion
Journal:  Brain Res Brain Res Rev       Date:  2001-03

5.  Inhibition of amyloid beta-protein production in neural cells by the serine protease inhibitor AEBSF.

Authors:  M Citron; T S Diehl; A Capell; C Haass; D B Teplow; D J Selkoe
Journal:  Neuron       Date:  1996-07       Impact factor: 17.173

6.  Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia.

Authors:  E Tarkowski; K Blennow; A Wallin; A Tarkowski
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

7.  A meta-analysis of cytokines in Alzheimer's disease.

Authors:  Walter Swardfager; Krista Lanctôt; Lana Rothenburg; Amy Wong; Jaclyn Cappell; Nathan Herrmann
Journal:  Biol Psychiatry       Date:  2010-08-08       Impact factor: 13.382

8.  Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation.

Authors:  Christina Therapontos; Lynda Erskine; Erin R Gardner; William D Figg; Neil Vargesson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-11       Impact factor: 11.205

9.  Roles of nitric oxide in tumor growth.

Authors:  D C Jenkins; I G Charles; L L Thomsen; D W Moss; L S Holmes; S A Baylis; P Rhodes; K Westmore; P C Emson; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Neurodegeneration in Alzheimer's disease: caspases and synaptic element interdependence.

Authors:  Dale E Bredesen
Journal:  Mol Neurodegener       Date:  2009-06-26       Impact factor: 14.195

View more
  8 in total

1.  MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.

Authors:  H Q Mu; Y H He; S B Wang; S Yang; Y J Wang; C J Nan; Y F Bao; Q P Xie; Y H Chen
Journal:  Clin Transl Oncol       Date:  2019-10-30       Impact factor: 3.405

2.  N-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge.

Authors:  Shih Chang Hsueh; Weiming Luo; David Tweedie; Dong Seok Kim; Yu Kyung Kim; Inho Hwang; Jung-Eun Gil; Baek-Soo Han; Yung-Hsiao Chiang; Warren Selman; Barry J Hoffer; Nigel H Greig
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-30

3.  Synthesis and Bioactivity of Hydrazide-Hydrazones with the 1-Adamantyl-Carbonyl Moiety.

Authors:  Van Hien Pham; Thi Phuong Dung Phan; Dinh Chau Phan; Binh Duong Vu
Journal:  Molecules       Date:  2019-11-05       Impact factor: 4.411

Review 4.  Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders.

Authors:  Yoo Jin Jung; David Tweedie; Michael T Scerba; Dong Seok Kim; Maria Francesca Palmas; Augusta Pisanu; Anna R Carta; Nigel H Greig
Journal:  Front Neurosci       Date:  2021-03-29       Impact factor: 4.677

5.  Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs.

Authors:  Megan L Peach; Shaunna L Beedie; Cindy H Chau; Matthew K Collins; Suzana Markolovic; Weiming Luo; David Tweedie; Christian Steinebach; Nigel H Greig; Michael Gütschow; Neil Vargesson; Marc C Nicklaus; William D Figg
Journal:  Molecules       Date:  2020-12-02       Impact factor: 4.411

6.  Synthesis, Characterization and Biological Evaluation of Metal Adamantyl 2-Pyridylhydrazone Complexes.

Authors:  Ihsan A Shehadi; Fatima-Azzahra Delmani; Areej M Jaber; Hana Hammad; Murad A AlDamen; Raed A Al-Qawasmeh; Monther A Khanfar
Journal:  Molecules       Date:  2020-05-29       Impact factor: 4.411

Review 7.  Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments.

Authors:  Yoo Jin Jung; David Tweedie; Michael T Scerba; Nigel H Greig
Journal:  Front Cell Dev Biol       Date:  2019-12-04

8.  Rheumatoid Arthritis: Applicability of Ready-to-Use Human Cartilaginous Cells for Screening of Compounds with TNF-Alpha Inhibitory Activity.

Authors:  Larissa T Volova; Evgeniy I Pugachev; Victoria V Rossinskaya; Violetta V Boltovskaya; Dmitry A Dolgushkin; Natalya Ossina
Journal:  Biomolecules       Date:  2020-11-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.